Phio Pharmaceuticals Corp Stock Analysis
| PHIO Stock | USD 1.47 0.10 6.37% |
Phio Pharmaceuticals Corp is undervalued with Real Value of 19.42 and Hype Value of 1.67. The main objective of Phio Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Phio Pharmaceuticals Corp is worth, separate from its market price. There are two main types of Phio Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Phio Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Phio Pharmaceuticals is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Phio Stock trading window is adjusted to America/New York timezone.
Phio |
Phio Stock Analysis Notes
The company has price-to-book ratio of 1.61. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Phio Pharmaceuticals Corp recorded a loss per share of 14.81. The entity last dividend was issued on the 15th of January 2020. The firm had 1:9 split on the 5th of July 2024. Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts. Phio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To find out more about Phio Pharmaceuticals Corp contact the company at 508 767 3861 or learn more at https://phiopharma.com.Phio Pharmaceuticals Corp Investment Alerts
| Phio Pharmaceuticals is way too risky over 90 days horizon | |
| Phio Pharmaceuticals may become a speculative penny stock | |
| Phio Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (10.83 M) with loss before overhead, payroll, taxes, and interest of (7.01 M). | |
| Phio Pharmaceuticals Corp currently holds about 18.02 M in cash with (10.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32. | |
| Phio Pharmaceuticals has a frail financial position based on the latest SEC disclosures |
Phio Pharmaceuticals Corp Upcoming and Recent Events
Earnings reports are used by Phio Pharmaceuticals to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Phio Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.02 M.Technical Drivers
As of the 25th of February, Phio Pharmaceuticals holds the Semi Deviation of 10.33, risk adjusted performance of 0.0518, and Coefficient Of Variation of 1749.39. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Phio Pharmaceuticals, as well as the relationship between them.Phio Pharmaceuticals Corp Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Phio Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Phio Pharmaceuticals Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Phio Pharmaceuticals Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Phio Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Phio Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Phio Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Phio Pharmaceuticals Outstanding Bonds
Phio Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Phio Pharmaceuticals Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Phio bonds can be classified according to their maturity, which is the date when Phio Pharmaceuticals Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Phio Pharmaceuticals Predictive Daily Indicators
Phio Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Phio Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Phio Pharmaceuticals Forecast Models
Phio Pharmaceuticals' time-series forecasting models are one of many Phio Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Phio Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Phio Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Phio Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Phio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Phio Pharmaceuticals. By using and applying Phio Stock analysis, traders can create a robust methodology for identifying Phio entry and exit points for their positions.
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts. Phio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Phio Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.